Ralf Rosskamp will become Dicerna Pharmaceuticals Inc.'s chief medical officer on June 15.
Rosskamp was previously the chief medical officer of Summit Therapeutics PLC.
Discover more about S&P Global’s offerings
Dicerna appoints chief medical officer
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Ralf Rosskamp will become Dicerna Pharmaceuticals Inc.'s chief medical officer on June 15.
Rosskamp was previously the chief medical officer of Summit Therapeutics PLC.